US7691598B2
(en)
*
|
2001-03-30 |
2010-04-06 |
Nanoprobes, Inc. |
Method for detecting a target molecule by metal deposition
|
US7888060B2
(en)
*
|
2001-03-30 |
2011-02-15 |
Nanoprobes, Inc. |
Method for detecting a target using enzyme directed deposition of elemental metal
|
US7642064B2
(en)
*
|
2003-06-24 |
2010-01-05 |
Ventana Medical Systems, Inc. |
Enzyme-catalyzed metal deposition for the enhanced detection of analytes of interest
|
CA2609702C
(en)
|
2005-04-28 |
2013-05-28 |
Ventana Medical Systems, Inc. |
Antibody conjugates via heterobifunctional peg linkers
|
CA2631005C
(en)
*
|
2005-11-23 |
2017-02-28 |
Ventana Medical Systems, Inc. |
Molecular conjugate
|
DK2442107T3
(da)
|
2006-11-01 |
2014-05-19 |
Ventana Med Syst Inc |
Haptener, haptenkonjugater, sammensætninger deraf og fremgangsmåde til deres fremstilling og anvendelse
|
JP4920553B2
(ja)
*
|
2006-11-08 |
2012-04-18 |
富士フイルム株式会社 |
イムノクロマトグラフキット
|
CA2687178C
(en)
|
2007-05-23 |
2014-02-04 |
Ventana Medical Systems, Inc. |
Polymeric carriers for immunohistochemistry and in situ hybridization
|
FR2924601A1
(fr)
*
|
2007-12-07 |
2009-06-12 |
Oreal |
Composes diphosphate d'hydroquinone et leur utilisation pour depigmenter la peau.
|
CA2720728C
(en)
|
2008-06-05 |
2018-04-03 |
Ventana Medical Systems, Inc. |
Compositions comprising nanomaterials and method for using such compositions for histochemical processes
|
DK2334827T3
(da)
|
2008-08-22 |
2015-06-15 |
Ventana Med Syst Inc |
Metode til kromogen påvisning af to eller flere målmolekyler i en enkelt prøve
|
KR101027036B1
(ko)
*
|
2009-05-28 |
2011-04-11 |
주식회사 인포피아 |
금 이온의 환원에 의한 측방유동 분석에서의 신호 증폭 방법 및 이를 이용한 측방유동 분석 디바이스
|
BR112012016233A2
(pt)
|
2009-12-31 |
2017-03-07 |
Ventana Med Syst Inc |
métodos para produzir uma sonda de ácido nucleico, sonda de ácido nucleico isolado e kit
|
DK2539355T3
(da)
|
2010-02-26 |
2017-01-02 |
Ventana Med Syst Inc |
IN-SITU-hybridisering med polytag-prober
|
ES2636908T3
(es)
|
2010-04-27 |
2017-10-10 |
Ventana Medical Systems, Inc. |
Conjugados de nanopartícula-anticuerpo y procedimientos para producir y usar dichos conjugados
|
EP2588144B1
(de)
|
2010-07-02 |
2018-05-09 |
Ventana Medical Systems, Inc. |
Nachweis von zielmolekülen mit massenmarkierungen und massenspektrometrie
|
US9103762B2
(en)
|
2010-10-28 |
2015-08-11 |
Eth Zurich |
Method for electrical detection of biomolecules by metal dissolution and Assay kit therefore
|
EP2659000B1
(de)
|
2010-12-30 |
2016-08-10 |
Ventana Medical Systems, Inc. |
Verbesserte ablagerung von chromogenen mit pyrimidinanaloga
|
US8703439B1
(en)
|
2011-01-31 |
2014-04-22 |
Linda Lester |
Point of care iodine sensor
|
CN103534359B
(zh)
|
2011-03-14 |
2016-07-06 |
文塔纳医疗系统公司 |
分析染色体易位的方法及其系统
|
WO2012151111A1
(en)
|
2011-05-04 |
2012-11-08 |
Htg Molecular Diagnostics, Inc. |
Quantitative nuclease protection assay (qnpa) and sequencing (qnps) improvements
|
WO2013167387A1
(en)
|
2012-05-10 |
2013-11-14 |
Ventana Medical Systems, Inc. |
Uniquely specific probes for pten, pik3ca, met, top2a, and mdm2
|
ES2648176T3
(es)
|
2012-07-12 |
2017-12-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Métodos de predicción del tiempo de supervivencia y de la respuesta al tratamiento de un paciente que padece un cáncer sólido con un distintivo de al menos 7 genes
|
WO2014048942A1
(en)
|
2012-09-25 |
2014-04-03 |
Ventana Medical Systems, Inc. |
Probes for pten, pik3ca, met, and top2a, and method for using the probes
|
WO2014145458A1
(en)
|
2013-03-15 |
2014-09-18 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Nucleic acid-tagged compositions and methods for multiplexed protein-protein interaction profiling
|
WO2015036405A1
(en)
|
2013-09-10 |
2015-03-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing and treating basal cell carcinoma
|
WO2015069787A1
(en)
|
2013-11-05 |
2015-05-14 |
Htg Molecular Diagnostics, Inc. |
Methods for detecting nucleic acids
|
JP6825915B2
(ja)
|
2014-02-24 |
2021-02-03 |
ヴェンタナ メディカル システムズ, インク. |
標識された2’−o−メチルrnaオリゴヌクレオチドプローブ及びシグナル増幅系を使用する自動rna検出
|
JP6626097B2
(ja)
|
2014-06-06 |
2019-12-25 |
ヴェンタナ メディカル システムズ, インク. |
乳がんにおける腫瘍内her2不均質性の意義及びそのための使用
|
AU2015326827B2
(en)
|
2014-10-02 |
2019-11-07 |
Ventana Medical Systems, Inc. |
Polymers and conjugates comprising the same
|
EP3009147A1
(de)
|
2014-10-16 |
2016-04-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Verfahren zur Behandlung von resistenten Glioblastomen
|
WO2016124558A1
(en)
|
2015-02-03 |
2016-08-11 |
Ventana Medical Systems, Inc. |
Histochemical assay for evaluating expression of programmed death ligand 1 (pd-l1)
|
WO2016146654A1
(en)
|
2015-03-16 |
2016-09-22 |
Ventana Medical Systems, Inc. |
Materials and methods for detecting androgen receptor splice variants and uses thereof
|
WO2016166169A1
(en)
|
2015-04-17 |
2016-10-20 |
Spring Bioscience Corporation |
Antibodies, compositions, and immunohistochemistry methods for detecting c4.4a
|
WO2016189065A1
(en)
|
2015-05-26 |
2016-12-01 |
Ventana Medical Systems, Inc. |
Method and system for assessing stain quality for in-situ hybridization and immunohistochemistry
|
WO2017029391A1
(en)
|
2015-08-20 |
2017-02-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method for treating cancer
|
WO2017055321A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of fibroblasts in a tissue sample
|
WO2017055319A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of b cells in a tissue sample
|
WO2017055326A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of myeloid dendritic cells in a tissue sample
|
WO2017055324A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of cells of monocytic origin in a tissue sample
|
WO2017055320A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of cytotoxic lymphocytes in a tissue sample
|
WO2017055327A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of endothelial cells in a tissue sample
|
WO2017055322A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of neutrophils in a tissue sample
|
WO2017055325A1
(en)
|
2015-09-29 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of nk cells in a tissue sample
|
WO2017060397A1
(en)
|
2015-10-09 |
2017-04-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of subjects suffering from melanoma metastases
|
WO2017067944A1
(en)
|
2015-10-19 |
2017-04-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of subjects suffering from triple negative breast cancer
|
EP3408410B1
(de)
|
2016-01-26 |
2023-12-20 |
Ventana Medical Systems, Inc. |
Prädiktiver diagnostischer arbeitsfluss für tumore mithilfe automatisierter dissektion, sequenzierung der nächsten generation und automatisierte objektträgerfärber
|
CA3016555A1
(en)
|
2016-03-08 |
2017-09-14 |
Ventana Medical Systems, Inc. |
Multiplexed immunohistochemistry using recombinant antibodies with epitope tags
|
WO2017182834A1
(en)
|
2016-04-19 |
2017-10-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method for treating resistant glioblastoma
|
WO2017202962A1
(en)
|
2016-05-24 |
2017-11-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of non small cell lung cancer (nsclc) that coexists with chronic obstructive pulmonary disease (copd)
|
WO2018011107A1
(en)
|
2016-07-11 |
2018-01-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of er-alpha 46 in methods and kits for assessing the status of breast cancer
|
WO2018011166A2
(en)
|
2016-07-12 |
2018-01-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for quantifying the population of myeloid dendritic cells in a tissue sample
|
WO2018046736A1
(en)
|
2016-09-12 |
2018-03-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of patients suffering from cancer
|
WO2018055080A1
(en)
|
2016-09-22 |
2018-03-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for reprograming immune environment in a subject in need thereof
|
EP3516397A1
(de)
|
2016-09-23 |
2019-07-31 |
Ventana Medical Systems, Inc. |
Verfahren und systeme zur bewertung extrazellulärer matrixbiomarker in tumorproben
|
WO2018091419A1
(en)
|
2016-11-15 |
2018-05-24 |
Ventana Medical Systems, Inc. |
Compositions and methods for prognosing and treating colorectal cancer
|
EP3555622B1
(de)
|
2016-12-19 |
2023-02-22 |
Ventana Medical Systems, Inc. |
Verfahren und systeme zur quantitativen immunhistochemie
|
CN110121364A
(zh)
|
2016-12-19 |
2019-08-13 |
文塔纳医疗系统公司 |
肽核酸缀合物
|
WO2018122245A1
(en)
|
2016-12-28 |
2018-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting the survival time of patients suffering from cms3 colorectal cancer
|
WO2018122249A1
(en)
|
2016-12-28 |
2018-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of patients suffering from a microsatellite stable colorectal cancer
|
WO2018146239A1
(en)
|
2017-02-10 |
2018-08-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Biomarker for outcome in aml patients
|
WO2018162404A1
(en)
|
2017-03-06 |
2018-09-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Biomarker for outcome in aml patients
|
WO2018172540A1
(en)
|
2017-03-24 |
2018-09-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method to predict the progression of alzheimer's disease
|
WO2018189215A1
(en)
|
2017-04-12 |
2018-10-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for predicting the survival time of a patient suffering from hepatocellular carcinoma
|
CN107189988B
(zh)
*
|
2017-07-17 |
2019-08-30 |
江南大学 |
一株分泌抗丁香酚单克隆抗体的杂交瘤细胞株cs12及其应用
|
WO2019020556A1
(en)
|
2017-07-24 |
2019-01-31 |
Ventana Medical Systems, Inc. |
METHODS AND SYSTEMS FOR ASSESSING INFILTRAT OF IMMUNE CELLS IN TUMOR SAMPLES
|
WO2019038219A1
(en)
|
2017-08-21 |
2019-02-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
NEW PROGNOSTIC METHOD OF PANCREATIC CANCER
|
WO2019043138A1
(en)
|
2017-09-01 |
2019-03-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
METHOD FOR PREDICTING OUTCOME OF CANCER
|
EP3692368A1
(de)
|
2017-09-25 |
2020-08-12 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Verwendung von vnn1 als biomarker und therapeutisches target bei sarkomen
|
JP2021507695A
(ja)
|
2017-12-18 |
2021-02-25 |
ヴェンタナ メディカル システムズ, インク. |
ペプチド核酸コンジュゲート
|
DK3746790T3
(da)
|
2018-01-31 |
2023-12-11 |
Ventana Med Syst Inc |
Fremgangsmåder og systemer til evaluering af immuncelleinfiltrat i kolorektal stadie III cancer
|
WO2019207030A1
(en)
|
2018-04-26 |
2019-10-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting a response with an immune checkpoint inhibitor in a patient suffering from a lung cancer
|
WO2019224153A1
(en)
|
2018-05-21 |
2019-11-28 |
Genentech, Inc. |
Her2 heterogeneity as a biomarker in cancer
|
WO2020016266A1
(en)
|
2018-07-17 |
2020-01-23 |
Ventana Medical Systems, Inc. |
Materials and methods for detecting fusion proteins
|
WO2020053376A1
(en)
|
2018-09-13 |
2020-03-19 |
Ventana Medical Systems, Inc. |
Histochemical and cytochemical methods for detecting ntrk fusion proteins
|
WO2020072348A1
(en)
|
2018-10-01 |
2020-04-09 |
Ventana Medical Systems, Inc. |
Methods and systems for predicting response to pd-1 axis directed therapeutics
|
WO2020089432A1
(en)
|
2018-11-02 |
2020-05-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New prognostic method of pancreatic cancer
|
WO2020089428A1
(en)
|
2018-11-02 |
2020-05-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New prognostic method of pancreatic cancer
|
EP3884259A1
(de)
|
2018-11-20 |
2021-09-29 |
Ventana Medical Systems, Inc. |
Verfahren und systeme zur herstellung und analyse von zellulären proben für morphologische merkmale und biomarkerexpression
|
WO2020141199A1
(en)
|
2019-01-03 |
2020-07-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for enhancing cd8+ t cell-dependent immune responses in subjects suffering from cancer
|
WO2020148349A1
(en)
|
2019-01-16 |
2020-07-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Variants of erythroferrone and their use
|
WO2020161125A1
(en)
|
2019-02-05 |
2020-08-13 |
Ventana Medical Systems, Inc. |
Methods and systems for evaluation of immune cell infiltrate in stage iv colorectal cancer
|
US20220098674A1
(en)
|
2019-02-13 |
2022-03-31 |
Inserm (Institut National De La Santé Et Dr La Recherch Médicale) |
Methods and compositions for selecting a cancer treatment in a subject suffering from cancer
|
WO2020182932A1
(en)
|
2019-03-13 |
2020-09-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New gene signatures for predicting survival time in patients suffering from renal cell carcinoma
|
WO2020193740A1
(en)
|
2019-03-28 |
2020-10-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New strategy for treating pancreatic cancer
|
WO2020201362A2
(en)
|
2019-04-02 |
2020-10-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting and preventing cancer in patients having premalignant lesions
|
EP3959340A1
(de)
|
2019-04-24 |
2022-03-02 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Verfahren zur vorhersage der reaktion von antipsychotischen wirkstoffen
|
WO2020229521A1
(en)
|
2019-05-14 |
2020-11-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for inhibiting or reducing bacterial biofilms on a surface
|
WO2021001539A1
(en)
|
2019-07-04 |
2021-01-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New strategy to detect and treat eosinophilic fasciitis
|
WO2021044012A1
(en)
|
2019-09-05 |
2021-03-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method of treatment and pronostic of acute myeloid leukemia
|
WO2021074391A1
(en)
|
2019-10-17 |
2021-04-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing nasal intestinal type adenocarcinomas
|
WO2021173674A1
(en)
|
2020-02-26 |
2021-09-02 |
A2 Biotherapeutics, Inc. |
Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
|
US20230113705A1
(en)
|
2020-02-28 |
2023-04-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing, prognosing and managing treatment of breast cancer
|
WO2021186014A1
(en)
|
2020-03-20 |
2021-09-23 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for predicting the survival time of a patient suffering from a cancer
|
CN115552248A
(zh)
|
2020-05-07 |
2022-12-30 |
文塔纳医疗系统公司 |
用于评价肿瘤样品中egfr和egfr配体表达的组织化学系统和方法
|
US20230250426A1
(en)
|
2020-06-10 |
2023-08-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for treating and prognosing cancer like glioblastoma
|
US20230218608A1
(en)
|
2020-06-18 |
2023-07-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New strategy for treating pancreatic cancer
|
WO2022018163A1
(en)
|
2020-07-22 |
2022-01-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for predicting survival time in patients suffering from cancer
|
EP4217399A1
(de)
|
2020-09-22 |
2023-08-02 |
Roche Diagnostics GmbH |
Antikörper spezifisch für alpha-1,6-kern-fucosyliertes psa und fucosylierte fragmente davon
|
WO2022064049A1
(en)
|
2020-09-28 |
2022-03-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for diagnosing brucella infection
|
WO2022084327A1
(en)
|
2020-10-20 |
2022-04-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for predicting the response to tnf inhibitors
|
EP4240874A1
(de)
|
2020-11-06 |
2023-09-13 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
Verfahren zur diagnose und behandlung des polyzystischen ovarialsyndroms (pcos)
|
WO2022135753A1
(en)
|
2020-12-21 |
2022-06-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for prognosis the humoral response of a subject prior to vaccination
|
WO2022136252A1
(en)
|
2020-12-21 |
2022-06-30 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for prognosis the humoral response of a subject prior to vaccination
|
WO2022152698A1
(en)
|
2021-01-12 |
2022-07-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of npdk-d to evaluate cancer prognosis
|
WO2022171611A1
(en)
|
2021-02-09 |
2022-08-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to pronostic lung cancer
|
WO2022194949A1
(en)
|
2021-03-17 |
2022-09-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for diagnosing pancreatic cancer
|
WO2022207566A1
(en)
|
2021-03-29 |
2022-10-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New method to evaluate pancreatic cancer prognosis
|
EP4326903A1
(de)
|
2021-04-23 |
2024-02-28 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Verfahren und zusammensetzungen zur behandlung von krankheiten im zusammenhang mit zellalterungsansammlung
|
WO2023280790A1
(en)
|
2021-07-05 |
2023-01-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Gene signatures for predicting survival time in patients suffering from renal cell carcinoma
|
WO2023089159A1
(en)
|
2021-11-22 |
2023-05-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New strategy targeting stroma/tumor cell crosstalk to treat a cancer
|
WO2023144303A1
(en)
|
2022-01-31 |
2023-08-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Cd38 as a biomarker and biotarget in t-cell lymphomas
|
WO2023152133A1
(en)
|
2022-02-08 |
2023-08-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for diagnosing colorectal cancer
|
WO2024061930A1
(en)
|
2022-09-22 |
2024-03-28 |
Institut National de la Santé et de la Recherche Médicale |
New method to treat and diagnose peripheral t-cell lymphoma (ptcl)
|